Effect of curcumin on lipid profile, fibrosis, and apoptosis in liver tissue in abemaciclib-administered rats

References

• Abd Rashid, N., et al., 2020. Polygonum minus essential oil modulates cisplatin-induced hepatotoxicity through inflammatory and apoptotic pathways. EXCLI Journal, 19, 1246–1265.
   PubMed Web of Science ®Google Scholar
• Abdelfattah-Hassan, A., et al., 2019. Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage. Complementary Therapies in Medicine, 46, 95–102.
   PubMed Web of Science ®Google Scholar
• Abdel-Reheim, M.A., et al., 2022. Quillaja saponaria bark saponin attenuates methotrexate induced hepatic oxidative stress, inflammation and associated liver injury in rats. Journal of Applied Pharmaceutical Science, 12 (5), 129–141.
   Google Scholar
• Adewale, O.O., et al., 2019. Curcumin protects sodium nitrite-induced hepatotoxicity in Wistar rats. Toxicology Reports., 6, 1006–1011.
   PubMed Web of Science ®Google Scholar
• Al-Hajm, A.Y.S., and Ozgun, E., 2022. Effects of acrylamide on protein degradation pathways in human liver-derived cells and the efficacy of N-acetylcysteine and curcumin. Drug and Chemical Toxicology, 45 (4), 1536–1543.
   PubMed Web of Science ®Google Scholar
• Ali, F.E., et al., 2020. Ursodeoxycholic acid abrogates gentamicin-induced hepatotoxicity in rats: role of NF-κB-p65/TNF-α, Bax/Bcl-xl/Caspase-3, and eNOS/iNOS pathways. Life Sciences, 254, 117760.
   PubMed Web of Science ®Google Scholar
• Ali, S.A., Sharief, N.H., and Mohamed, Y.S., 2019. Hepatoprotective activity of some medicinal plants in Sudan. Evidence-Based Complementary and Alternative Medicine : eCAM, 2019, 2196315.
   PubMed Web of Science ®Google Scholar
• Aljobaily, N., et al., 2020. Creatine alleviates doxorubicin-ınduced liver damage by ınhibiting liver fibrosis, ınflammation, oxidative stress, and cellular senescence. Nutrients, 13 (1), 41.
   PubMed Web of Science ®Google Scholar
• Bilgic, S., and Ozgocmen, M., 2019. The protective effect of misoprostol against doxorubicin induced liver injury. Biotechnic & Histochemistry, 94 (8), 583–591.
   PubMed Web of Science ®Google Scholar
• Cengiz, M., et al., 2022. Escin attenuates oxidative damage, apoptosis and lipid peroxidation in a model of cyclophosphamide-induced liver damage. Drug and Chemical Toxicology, 45 (3), 1180–1187.
   PubMed Web of Science ®Google Scholar
• Corona, S.P. and Generali, D., 2018. Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2− advanced breast cancer. Drug Design, Development and Therapy, 12, 321–330.
   PubMed Web of Science ®Google Scholar
• da Costa, P., et al., 2017. Curcumin attenuates memory deficits and the impairment of cholinergic and purinergic signaling in rats chronically exposed to cadmium. Environmental Toxicology, 32 (1), 70–83.
   PubMed Web of Science ®Google Scholar
• Eggersmann, T.K., et al., 2019. CDK4/6 inhibitors expand the therapeutic options in breast cancer: palbociclib, ribociclib and abemaciclib. BioDrugs: Clinical İmmunotherapeutics, Biopharmaceuticals and Gene Therapy, 33 (2), 125–135.
   PubMed Web of Science ®Google Scholar
• Essawy, A.E., et al., 2018. Dual protective effect of ginger and rosemary extracts against CCl4-induced hepatotoxicity in rats. Environmental Science and Pollution Research İnternational, 25 (20), 19510–19517.
   PubMed Web of Science ®Google Scholar
• Farzaei, M.H., et al., 2018. Curcumin in liver diseases: a systematic review of the cellular mechanisms of oxidative stress and clinical perspective. Nutrients, 10 (7), 855.
   PubMed Web of Science ®Google Scholar
• Fisher, K., Vuppalanchi, R., and Saxena, R., 2015. Drug-induced liver injury. Archives of Pathology & Laboratory Medicine, 139 (7), 876–887.
   PubMed Web of Science ®Google Scholar
• Harbeck, N., et al., 2019. Breast cancer. Nature Reviews Disease Primers, 5 (1), 1–31.
   PubMedGoogle Scholar
• Hasan, M., et al., 2020. Growth-inhibitory effect of chitosan-coated liposomes encapsulating curcumin on MCF-7 breast cancer cells. Marine Drugs, 18 (4), 217.
   PubMed Web of Science ®Google Scholar
• Huyut, Z., et al., 2021. Comparison of the protective effects of curcumin and caffeic acid phenethyl ester against doxorubicin‐induced testicular toxicity. Andrologia, 53 (2), e13919.
   Web of Science ®Google Scholar
• Huyut, Z., et al., 2022. The protective effect of curcumin on cardiac markers and fibrosis in abemaciclib‐induced cardiac damage in rats. Journal of Biochemical and Molecular Toxicology, e2326. doi:10.1002/jbt.23226
   PubMed Web of Science ®Google Scholar
• Ibrahim Fouad, G. and Ahmed, K.A., 2022. Curcumin ameliorates doxorubicin-ınduced cardiotoxicity and hepatotoxicity via suppressing oxidative stress and modulating iNOS, NF-kappaB, and TNF-alpha in rats. Cardiovascular Toxicology, 22 (2), 152–166.
   PubMed Web of Science ®Google Scholar
• Kosovec, J.E., et al., 2017. CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease. Oncotarget, 8 (59), 100421–100432.
   PubMedGoogle Scholar
• Kotha, R.R. and Luthria, D.L., 2019. Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules, 24 (16), 2930.
   PubMed Web of Science ®Google Scholar
• Lamb, R., et al., 2013. Cell cycle regulators cyclin D1 and CDK4/6 have estrogen receptor-dependent divergent functions in breast cancer migration and stem cell-like activity. Cell. Cell Cycle, 12 (15), 2384–2394.
   PubMed Web of Science ®Google Scholar
• Liu, H., et al., 2017. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharmaceutical Biology, 55 (1), 1144–1148.
   PubMed Web of Science ®Google Scholar
• Mazani, M., et al., 2022. Protection of CCl4-induced hepatic and renal damage by linalool. Drug and Chemical Toxicology, 45 (3), 963–971.
   PubMed Web of Science ®Google Scholar
• Nagai, K., et al., 2016. Protective effects of taurine on doxorubicin-induced acute hepatotoxicity through suppression of oxidative stress and apoptotic responses. Anti-Cancer Drugs, 27 (1), 17–23.
   PubMed Web of Science ®Google Scholar
• Noorafshan, A. and Ashkani-Esfahani, S., 2013. A review of therapeutic effects of curcumin. Current Pharmaceutical Design, 19 (11), 2032–2046.
   PubMed Web of Science ®Google Scholar
• Novak, M., et al., 2017. Cytotoxicity and genotoxicity of anticancer drug residues and their mixtures in experimental model with zebrafish liver cells. The Science of the Total Environment, 601–602, 293–300.
   PubMed Web of Science ®Google Scholar
• Otto-Ślusarczyk, D., Graboń, W., and Mielczarek-Puta, M., 2016. Aspartate aminotransferase–key enzyme in the human systemic metabolism. Postepy Higieny i Medycyny Doswiadczalnej (Online), 70, 219–230.
   PubMedGoogle Scholar
• Oz, A. and Celik, O., 2016. Curcumin inhibits oxidative stress-induced TRPM2 channel activation, calcium ion entry and apoptosis values in SH-SY5Y neuroblastoma cells: Involvement of transfection procedure. Molecular Membrane Biology, 33 (3–5), 76–88.
   PubMed Web of Science ®Google Scholar
• Sloop, J.T., et al., 2019. Effects of platinum-based anticancer drugs on the trace element profile of liver and kidney tissue from mice. Journal of Trace Elements in Medicine and Biology, 54, 62–68.
   PubMed Web of Science ®Google Scholar
• Song, X., et al., 2019. Molecular targets of curcumin in breast cancer (Review). Molecular Medicine Reports, 19 (1), 23–29.
   PubMed Web of Science ®Google Scholar
• Thornburg, J.M., et al., 2008. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Research, 10 (5), 1–12.
   Web of Science ®Google Scholar
• Tohamy, H.G., et al., 2022. Hepatorenal protective effect of nano-curcumin against nanocopper oxide-mediated toxicity in rats: behavioral performance, antioxidant, anti-inflammatory, apoptosis, and histopathology. Life Sciences, 292, 120296.
   PubMed Web of Science ®Google Scholar
• Uçar, B., et al., 2022. Relationship with nephrotoxicity of abemaciclib in rats protective effect of curcumin. Indian Journal of Biochemistry & Biophysics, 59 (10), 963–976.
   Web of Science ®Google Scholar
• Villegas, S.L., et al., 2018. Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment, 168 (1), 179–187.
   PubMed Web of Science ®Google Scholar
• Vincenzi, B., et al., 2016. Drug-induced hepatotoxicity in cancer patients-implication for treatment. Expert Opinion on Drug Safety, 15 (9), 1219–1238.
   PubMed Web of Science ®Google Scholar
• Vincenzi, B., et al., 2018. The use of SAMe in chemotherapy-induced liver injury. Critical Reviews in Oncology/Hematology, 130, 70–77.
   PubMed Web of Science ®Google Scholar
• Wang, J.L., et al., 2018. Antifibrotic role of PGC-1alpha-siRNA against TGF-beta1-induced renal interstitial fibrosis. Experimental Cell Research, 370 (1), 160–167.
   PubMed Web of Science ®Google Scholar
• Yıldızhan, K., et al., 2020. Protective effects of Urtica dioica L. seed extract on liver tissue injury and antioxidant capacity in irradiated rats. Brazilian Journal of Pharmaceutical Sciences, 56, e18354 (1–9).
   Web of Science ®Google Scholar
• Yıldızhan, K., Huyut, Z., and Altındağ, F., 2022. Involvement of TRPM2 channel on doxorubicinınduced experimental cardiotoxicity model: protective role of selenium. Biological Trace Element Research. doi:10.1007/s12011-022-03377-2
   PubMed Web of Science ®Google Scholar
• Zhong, W., et al., 2016. Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-kappaB related signaling. Biomedicine & Pharmacotherapy, 83, 302–313.
   PubMed Web of Science ®Google Scholar